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(57) ABSTRACT 
The present invention involves an apparatus for implement-
ing hydro-acoustic therapy for the lungs on a patient and a 
method for the hydro-acoustic therapy (HAT) for the lungs. 
The HAT apparatus includes a chamber filled with a fluid, 
particularly water. The HAT apparatus also has an acoustic 
generator for generating low frequency acoustic waves in 
the fluid. A patient is positioned in the chamber and partially 
submersed in the fluid for treatment. In another aspect, a 
method for implementing hydro-acoustic therapy for the 
lungs includes the step of placing a person in the apparatus 
described above such that a body of the person is immersed 
in said occurs. Then, introducing acoustic vibrations into the 
fluid. The vibrations, if properly tuned, cause the mobiliza-
tion of respiratory secretions in the person. 
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APPARATUS AND METHOD FOR 
IMPLEMENTING HYDRO-ACOUSTIC 
THERAPY FOR THE LUNGS 
CROSS-REFERENCE TO RELATED 
APPLICATION 
This application claims priority to copending U.S. provi-
sional application entitled, "Hydroacoustic Lung Therapy," 
having Ser. No. 60/200,484, filed Apr. 28, 2000, which is 
entirely incorporated herein by reference. 
TECHNICAL FIELD 
The present invention relates generally to therapeutic 
treatments for medical patients, and, more particularly, to a 
method and apparatus for causing the mobilization of res-
piratory secretions through hydro-acoustic lung therapy. 
BACKGROUND OF THE INVENTION 
Cystic Fibroses (CF) is a recessive genetic disease caused 
by mutations in a membrane-associated protein, which pro-
motes transcellular movement of chloride ions in airway 
epithelia and other tissues. In the lungs, defective function of 
the membrane-associated protein results in abnormally thick 
secretions in the lower airways which plug small bronchi-
oles and provide an environment for chronic endobronchin-
cal bacterial infection. Despite recruitment of vast numbers 
of neutrophils, bacterial clearance is ineffective, and the 
airways of the lungs are damaged by free radical species and 
prostheses released by the neutrophils. In addition, as the 
recruited neutrophils decompose in the airway, the DNA 
from their nuclei markedly increase the viscosity of the 
lower airway secretions, leading to further airway blockage 
and infection. The end result of this above-identified cycle is 
destruction of bronchial airway structure and progressive 
loss of lung function in the CF patient. Despite significant 
improvements in clinical management, respiratory failure 
and related pulmonary complications account for over 
ninety percent of CF mortality. 
Since pulmonary disease is the primary cause of morbid-
ity and mortality in CF, considerable effort has been directed 
2 
Currently, the most common form of chest physiotherapy 
is manual chest physiotherapy. In manual chest physio-
therapy a trained caregiver strikes the patient's chest with 
cupped hands. This striking motion is usually complimented 
5 with postural drainage, a systematic form of directing mucus 
from the peripheral to the central airways through a series of 
gravity-assisted patient positions and therapist simulation. 
Each physiotherapy session is coupled with a period of 
huffing and coughing to remove sputum. While this method 
10 of therapy is somewhat effective, manual chest physio-
therapy is labor intensive because it must be performed by 
a therapist or trained caregiver. The efficacy of manual chest 
therapy depends on the skill and diligence of the therapist. 
For this reason, manual chest physiotherapy may be expen-
15 sive and/or time consuming for the therapist and patient. 
Additionally, the striking of the chest may cause discomfort 
to the patient or damage to a more fragile patient's ribcage. 
Various mechanical devices have been developed in an 
effort to standardize and increase the efficiency of chest 
20 physiotherapy. Among the most widely employed forms of 
mechanical chest physiotherapy are various hand-held com-
pressors which deliver external chest vibration, high fre-
quency chest compression administered through an inflat-
able jacket, and devices such as a FLUTTER TM device 
25 which delivers internal airway stimulation from pulsating 
airflow via the mouth. 
The high frequency chest compression (HFCC) method of 
chest physiotherapy is very commonly employed today. 
HFCC is administered via a product called the VEST™. In 
30 clinical studies with CF patients, use of the VEST™ has 
been shown to be a practical, automated method of chest 
physiotherapy, and is an improvement over manual therapy 
to the extent that it allows for increased patient indepen-
dence. HFCC, via oscillating chest compression, stimulates 
35 
40 
cough with its associated mucus shearing airflow spikes, and 
the compression of the thorax during expiration results in 
increased expiratory airflow. It is hypothesized also that 
HFCC at certain frequencies promotes a longer ciliary brush 
stroke, thereby enhancing mucus transport. 
The VEST™ device consists of an inflatable vest structure 
which is strapped onto the patient's torso. The inflatable vest 
structure is attached by supply tubes to an air compressor. 
The air compressor is powered such that it can force air into 
45 
the vest worn by the patient at set frequencies and ampli-
tudes. In this way, the vest that the patient wears is inflated 
to compress the patient's chest at set frequencies and ampli-
tudes. 
to increase the mobilization of the abnormally thick airway 
secretions through various forms of chest physiotherapy. In 
the normal respiratory system, there are three primary mucus 
transport mechanisms. First, as is predominate in the smaller 
airways of the lungs, is a conveyor-like effect of a coordi-
nated beating of airway epthocilia. In the larger airways, the 
second method of mucus transport is the high velocity 
airflow associated with coughing. Coughing tends to sheer 
mucus off airway surfaces and propels it towards the phar- 50 
ynx. The third mechanism of transporting mucus through the 
lungs is termed cephalad airflow bias of tidal breathing. 
Cephalad airflow bias results from greater expiratory versus 
inspiratory airflow due to compression of the intrathorasic 
airways during expiration. However, the abnormal compo- 55 
sition and increased amount of tracheal bronchial secretions 
With the present mechanical devices such as the VEST™, 
the oscillating pressure administered to the chest wall is not 
transmitted equally across the chest to the underlying lung. 
Increased mucus transport only occurs in those portions of 
the lungs directly covered by the isolating pressure vest. In 
particular, with the VEST™ device the lungs are excited 
from the sides but not from the top or bottom. The pressure 
administered by the VEST™ device is not uniform. The 
pressures applied to the patient's chest varies greatly. 
Additionally, the frequency at which the vest operates is not 
fine-tuned such as to optimize airway stimulation with the 
least amount of applied external energy. Generally, in clini-
cal use of the VEST™, patients adjust the frequency and 
amplitude of the applied chest wall stimulation to what they 
believe provides the best results or to the maximum they can 
tolerate. 
in the airways of a CF patient impede all of these natural 
mechanisms of mucus clearance. 
For this reason, several forms of chest physiotherapy have 
been developed. These methods of chest physiotherapy are 60 
intended to assist in pulmonary mucus clearance and are 
presently widely used for CF patients. The mechanism 
underlying all modes of chest physiotherapy currently in use 
is vibration of the airway surfaces, either through external 
chest compression or by oscillatory airflow, to promote 65 
increased cephalad-induced and/or cough-induced mobili-
zation of airway secretions. 
In addition to the above-referenced shortcomings of the 
prior art chest physiotherapy regimens, the current methods 
of chest physiotherapy are generally quite uncomfortable. 
US 6,974,425 B2 
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Most of the current methods of chest physiotherapy require 
a force to be exerted on the external chest cavity of the 
patient. This is disadvantageous to all patients, but particu-
larly to those who are more prone to rib or chest injury due 
to the impact, such as frail or elderly patients and very young 5 
patients. 
Therefore, it would be desirable to have a method and 
apparatus for chest physiotherapy that does not involve a 
trained caregiver or physiotherapist, such as to minimize 
cost, increase the patient's independence, and also involves 10 
a marginal, if any amount of impact to the CF patient's 
chest. It is also desirable to have a method and apparatus for 
chest physiotherapy that does not cause discomfort to the 
patient, applies more uniform stimulation to the lungs and 
excites the entire lung. The invention described in detail 15 
below meets the limitations of the prior art. 
SUMMARY OF THE INVENTION 
Briefly described, the present invention comprises an 
apparatus for affecting hydro-acoustic therapy for the lungs 20 
on a patient and a method of implementing the hydro-
acoustic therapy (HAT) for the lungs. HAT, for purposes of 
this disclosure, encompasses treatment using acoustic 
vibrations, or sound, in a liquid environment. An embodi-
ment of a HAT apparatus comprises a chamber filled with a 25 
fluid, particularly water. The HAT apparatus also has an 
acoustic generator for generating low frequency acoustic 
waves in the fluid. A patient is positioned in the chamber and 
partially immersed in the fluid for treatment. Specifically, a 
patient submerged in a fluid, such as water, to a neck of the 30 
patient. 
In another aspect, a method for implementing hydro-
acoustic therapy for the lungs includes the step of placing a 
person in the apparatus described above such that a body of 
the person is immersed in said fluid. Then, introducing 35 
acoustic vibrations into the fluid occurs. The vibrations, if 
properly tuned, cause the mobilization of respiratory secre-
tions in the person. 
4 
not necessarily to scale, emphasis instead being placed upon 
clearly illustrating the principles of the present invention. 
Moreover, in the drawings, like reference numerals desig-
nate corresponding parts throughout the several views. 
FIG. 1 is a cut-away side view of an exemplary hydro-
acoustic therapy for the lungs apparatus according to the 
present invention. 
FIG. 2 is a cut-away side view of a second exemplary 
embodiment of a device for hydro-acoustic therapy for the 
lungs. 
FIG. 3 is a cut-away side view of the exemplary hydro-
acoustic therapy device of FIG. 1 without a patient. 
FIG. 4 is an exemplary plot of normalized amplitude 
versus frequency for determining a resonant frequency of a 
patient's lungs. 
DETAILED DESCRIPTION OF THE 
PREFERRED EMBODIMENT 
FIG. 1 is a cut-away side view of an exemplary hydro-
acoustic lung therapy ("HAT") apparatus 10. The exemplary 
HAT apparatus 10 includes a chamber 111 for holding a fluid 
12. As depicted in FIG. 1, the exemplary apparatus 10 has 
the fluid in the chamber 11, but the chamber 11 is not fully 
filled with the fluid 12. A person, or patient 13 is positioned 
in the fluid 12 such that a head region 14 of the patient 13 
protrudes above the surface 16 of the fluid 12. Preferably, the 
HAT apparatus 10 is designed such that the person 13 will 
sit on a supporting structure 17 in the fluid 12. 
I. Construction of the Preferred Embodiment 
The chamber 11 preferably comprises a cylindrically 
shaped cavity manufactured from a structurally rigid, or stiff 
material. The chamber 111 has a circular bottom wall 18 and 
a single, cylindrically shaped sidewall 19 attached to a 
periphery of the bottom wall 18. The top portion 21 of the 
chamber 11 is open. The particular shape of the chamber 11 
is not required to be cylindrical; however, a cylindrically 
shaped chamber 11 is preferable because the cylindrical 
shape insures uniform sound reflection and eliminates edge 
reflections of acoustical waves. The chamber 11 could be 
shaped as a cube or spherical, for example. These features 
are generally beneficial to the HAT method described below. 
Further, the chamber 11 of the preferred embodiment 10 is 
large enough so that the patient 13 can easily fit in the 
The HAT method and apparatus described herein can 
40 
result in effective treatment of many debilitating ailments. 
For example, HAT may prove to be a particularly effective 
treatment for cystic fibrosis patients, chronic obstructive 
lung disease, pneumonia, and lung cancer, by way of 
example. 
HAT is also an improvement over the prior art for several 
reasons. HAT can be operated such that a lung of the patient 
moves uniformly for more effective treatment. HAT does not 
require physical impact with a chest of the patient, such as 
required by HFCC. Additionally, HAT does not require the 50 
presence of a trained caregiver or physical therapist. Finally, 
45 chamber 11, as depicted in FIG. 1. The exemplary HAT 
apparatus 10 has a chamber that is 1.2 meters diameter and 
1.5 meters tall. The cylindrically shaped wall 19 of the 
exemplary HAT apparatus is approximately 0.125 meters 
thick. 
The cylindrical wall 19 of the chamber 11 of the exem-
plary HAT apparatus 10 is made of a steel reinforced 
concrete tube, normally used for underground water piping. 
The bottom wall 18 of the chamber 11 is made of steel. Of 
it is common to administer drugs to patients, such as cystic 
fibrosis patients, through airborne inhalants. It is believed 
that the absorption of air-delivered drugs, if administered 
during HAT, will increase due to the operation of HAT. 
course, it is not a requirement that the chamber 11 be 
55 constructed of a concrete material, or that the bottom wall 18 
be constructed of steel. The chamber 11 could also be Other systems, methods, features, and advantages of the 
present invention will be or become apparent to one with 
skill in the art upon examination of the following drawings 
and detailed description. It is intended that all such addi-
tional systems, methods, features, and advantages be 60 
included within this description, be within the scope of the 
present invention, and be protected by the accompanying 
claims. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The invention can be better understood with reference to 
the following drawings. The components in the drawings are 
constructed of a variety of other materials, for example, high 
density PVC, fiberglass, or similar materials. Indeed, it is not 
even a requirement that the chamber walls 18, 19 be 
acoustically rigid, though structural rigidity is preferred. 
However, the acoustic rigidity of the walls 18, 19 of the 
chamber 11 causes a high degree of acoustic reflection. If the 
walls 18, 19 are not acoustically rigid, the acoustic field 
energy is less uniform and more frequency dependent due to 
65 flexing of the walls. Although the acoustic performance of 
such a device might be somewhat poorer, the advantages of 
lighter weight and lower cost might make such a design 
US 6,974,425 B2 
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more desirable and such a design is encompassed within the 
scope of the present invention. 
The chamber 11 has an orifice 22 along a bottom wall 18. 
6 
As noted above, in the exemplary HAT apparatus 10, the 
chamber 11 is filled with a fluid 12. In the preferred 
embodiment, this fluid 12 comprises water. Water has been 
selected as the preferred fluid 12 because so much of the The orifice 22 is located at approximately the center of the 
bottom wall 18 and is covered by a flexible membrane 23. 
This membrane 23 may be manufactured of any appropriate 
flexible material, such as latex rubber. The membrane 23 is 
securely attached to the bottom wall 18 at the sides of the 
orifice 22 with an adhesive-such as Neoprene Gel, for 
example. 
5 human body is composed primarily of water. Indeed, only 
the human bones and the lungs are not primarily made of 
water. Because the human body is mostly water, there is no 
acoustical impedance mismatch across the transition from 
water to human flesh, blood, visceral organs, etc. . . . 
10 However, under certain circumstances as would be under-
stood with one having ordinary skill in the art, another fluid 
12 may be used in the HAT apparatus 10. 
A piston 24 is positioned directly under and in contact 
with the membrane 23. The piston 24 comprises a piston 
head 26 and a shaker arm 27. The shaker arm 27 connects 
the piston head 26 to a shaker apparatus 28, such as a 
Vibration Test Systems VTS 100 permanent magnet shaker. 
The piston 24 basically forms an acoustic generator that 15 
causes the membrane 23 to oscillate and generate acoustic 
waves in the fluid 12. While this particular shaker 28 is not 
required, the VTS 100 shaker has a maximum rated force 
peak sine wave of 100 lbf. or 444 N. This force output is 
adequate to generate the preferred amplitude of acoustic 20 
force, as will be discussed below. One with ordinary skill in 
the art could easily select a different shaker apparatus of the 
appropriate size, if desired. 
The shaker apparatus 28 is mounted on a support frame 29 
underneath the chamber 11 and attached via a power cord 31 25 
to an amplifier 32. An amplifier 32 to match the particular 
preferred shaker 28 is included in the VTS 100 package and 
is a solid state Crown Int. CE2000 amplifier with selectable 
voltage/current modes (model VTS 1991). In certain con-
figurations of a shaker 28, a separate amplifier 32 may not 30 
be necessary. The amplifier 32, and in turn the shaker 28, is 
preferably driven by a computer 33. The exemplary HAT 
apparatus 10 uses LABVIEW™ software on the computer 
The chamber 11 has a drain opening 34 and a fill opening 
36 in the bottom wall 18 of the chamber 11. The drain and 
fill openings 34, 36 can be of any appropriate size and are 
for draining the fluid 12 out of the chamber 11 and then 
replacing new fluid 12 into the chamber 11 respectively. The 
drain and fill openings 34, 36 may be equipped with appro-
priate covers 37, 38. Alternatively, one opening could be 
used to drain and fill the chamber 11. Also, one could elect 
to fill and drain the chamber 11 from the top 21 of the 
chamber, such as with a pump. 
The chamber 11 also has a pair of fluid circulation 
openings 39a, 39b in the chamber sidewall 19. Preferably, a 
fluid pump 41 is in communication with the circulation 
openings 39a, 39b by an outflow pipe 42 attached to the first 
opening 39a and an inflow pipe 43 attached to the second 
opening 39b. This permits the fluid 12 to be pumped out of 
the chamber 11, through the pump 41, and back into the 
chamber 11. This external circuit 41, 42, 43 keeps the fluid 
12 circulating in the chamber 11. In the preferred embodi-
ment 10, the pump 41 is in the form of a hot tub/spa water 
pump, such as an 87 liters per minute Gundfos water pump, 
for example. 
Also, it is preferred that the fluid 12 be heated to approxi-
mately 35° C., near body temperature, in order that a person 
13 in the chamber 11 will be comfortable while in the fluid 
12. For this reason, a water heater 44 is preferably connected 
along the inflow pipe 43. It is possible to raise the tempera-
33 to control the amplitudes and frequencies of the shaker 28 
and the piston 24. Other types of software could be used to 35 
control the shaker 28 and piston 24, for example, custom-
designed software. The computer 33 has the capability to 
convert analog input signals to digital and to convert digital 
signals to analog output. This is preferably accomplished 
with an Analog to Digital card in the computer 33. 40 ture of the fluid 12 to a level higher than body temperature. 
While the piston 24/shaker 28 arrangement described 
above is a preferred acoustic generator, or the preferred 
method for generating acoustic waves in the fluid 12, other 
arrangements are possible. Indeed, it is possible to generate 
acoustic waves in the fluid 12 of proper frequencies and 45 
amplitudes using one or more commercially available under-
water loudspeakers or transducers (either commercially 
available or custom designed) placed directly in the water. 
For example, electrodynamic, piezoelectric, hydraulic, 
magnetic, and electrostatic transducers could all be used 50 
with a HAT apparatus 10. One such other embodiment is 
described below in reference to FIG. 2. One having ordinary 
skill in the art would appreciate other ways of generating 
acoustic waves in the fluid 12 and these are all intended to 
This increased temperature may result in decreasing the 
viscosity of the sputum in the patient and possibly increasing 
the effectiveness of HAT. In the preferred embodiment, the 
water heater 44 is in the form of a hot tub/spa water heater, 
such as a Vulcan Electric Company 6 kilowatt heater. 
Within the chamber 11 of the preferred HAT apparatus 10, 
there is positioned a supporting structure 17 such that a 
person 3 undergoing treatment can sit in the fluid 12. The 
supporting structure 17 should preferably be positioned such 
that the patient's head 14 protrudes from above the fluid 
surface 16, as shown in FIG. 1. Because patients come in 
different sizes, the supporting structure 17 is preferably 
adjustable. 
Although any seat, or other similar structure may be used 
be included within the scope of the present disclosure. 
The size and materials of the piston head 26 are not 
critical to the present invention provided that the combina-
tion of piston 24, shaker 28, and amplifier 32 are capable of 
producing the required acoustic sound pressure levels at the 
lungs at the appropriate frequencies. However, the preferred 
piston head 26 is constructed of aluminum and is 0.29 
meters in diameter with a 0.01 meter thickness. Certainly 
other sizes, shapes, and construction materials may be just as 
effective with the HAT apparatus 10. One having ordinary 
skill in the art would be well aware of such variations and 
these variations are intended to be included in the scope of 
the present disclosure. 
55 in the preferred embodiment 10, the preferred supporting 
structure 17 comprises an inflatable chair 46 supported by an 
adjustable frame 47 constructed of PVC pipe. The inflatable 
chair 46 is filled with the fluid 12, and not air. In this way, 
any acoustical waves traveling through the chamber fluid 12 
60 will not "see" or be influenced by the chair 46 and will be 
transmitted through the chair 46 just as through the other 
fluid 12 in the chamber 11. Similarly, PVC has a very similar 
impedance to water, and if the fluid 12 is water, the frame 47 
will also not substantially affect the transmission of acoustic 
65 waves through the fluid medium 12 in the chamber 11. 
In the preferred embodiment of a HAT apparatus 10, the 
chamber 11 is supported off of the ground 48 and above the 
US 6,974,425 B2 
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piston 24/shaker 28 assembly by a structure 49. The struc-
ture 49 also supports a working platform 51. Of course, the 
platform 51 and the particular structure 49 depicted in FIG. 
8 
the chamber 61 is smaller than the chamber 11 of the first 
exemplary HAT apparatus depicted in FIG. 1. For example, 
where the chamber 11 of FIG. 1 is approximately 5 feet tall 
1 are not required. The structure 49 is comprised of steel 
support and the platform 51 is preferably comprised of 5 
wood. 
and 4 feet in diameter, the chamber 61 of the alternative 
embodiment 60 may be approximately 3 feet tall and only 3 
feet in diameter. 
Because the objective of the present device 10 is such that 
a person 13 can be placed in the chamber 11, it is preferred 
that a ladder 52 be supplied in order to permit easy ingress 
and egress from the chamber 11. Obviously, steps could be 
constructed to also permit easy ingress and egress from the 
chamber 11. Additionally, depending on the size of the 
chamber 11, it may be desirable to use another ladder (not 
shown) on the inside of the chamber 11 to permit a patient 
to descend into the chamber 11. 
As depicted in FIG. 1, a patient 13 is preferably seated in 
the chair 46. The frame 47 is then adjusted such that the top 
surface 16 of the fluid 12 is at about a neck 53 of the patient 
13. Then, a hydrophone 54 is preferably affixed about a chest 
region 56 of the patient 13. 
Additionally, in the alternative embodiment of a HAT 
apparatus 60 a piston is preferably not used as an acoustic 
generator, but a transducer device, or series of transducer 
10 devices 62, are used. The preferred home HAT apparatus 60 
uses an array of underwater speakers 62 as acoustic genera-
tors. 
With the exception of the material used for the chamber 
61, the size of the chamber 61 (which can be smaller than the 
15 chamber 11 described above), and the use of underwater 
speakers 62 to generate acoustic waves, the other primary 
elements of the preferred home HAT apparatus 60 are the 
same as the HAT apparatus 10 of FIG. 1. Indeed, the home 
HAT apparatus 60 also has a computer 33 to drive the 
20 speaker array 62 at a selected amplitude and frequency. The 
chamber 61 of the HAT apparatus 60 also has circulation 
openings 39a, 39b in fluid communication with a pump 41 
and a heater 44. 
Basically, a hydrophone is a device that responds to the 
pressure associated with underwater sound waves and con-
verts this response into electrical energy at a certain voltage 
amplitude proportional to the pressure amplitude of the 
sound waves. The voltage generated by a hydrophone can be 25 
read on a meter or by a computer through an analog to digital 
converter. A hydrophone can be thought of as the underwater 
equivalent of the microphone. A hydrophone such as a Bruel 
The HAT apparatus 60 also preferably has a supporting 
structure 17 comprising a chair 46 and an adjustable frame 
in the chamber 61. A hydrophone 54 is also affixed to the 
chest 56 of the patient 13 and connected to the computer 33 
via a data cable 57. The hydrophone 54, as above, permits 
the computer 33 to monitor and control the treatment & Kjaer 8103 piezoelectric hydrophone is preferred. The 
hydrophone 54 in FIG. 1 is connected to the computer 33 by 30 
a data cable 57. 
process. Notice that with the home embodiment 60, the 
chamber 61 is preferably designed with no supporting 
The hydrophone 54 is positioned adjacent to the chest 56 structure 49. 
II. Operation of the Preferred Embodiment 
The operation of the HAT apparatus 10 depicted in FIG. 
35 1 will now be described in a preferred method of imple-
menting HAT treatment for a patient 13. It should be 
understood that the method described below is also equally 
applicable to the alternative embodiment 60 depicted in FIG. 
of the patient 13, just below the sternum. Then, an adjustable 
Velcro TM strap 58 is positioned around the patient's chest 56 
and secures the hydrophone 54 to the chest 56 of the patient 
13. Preferably, the strap 58 is somewhat flexible and will 
expand with the breathing of the patient 13. The strap 58 is 
positioned so that it overlies the cable 57 that connects the 
hydrophone 54 to the computer 33, as depicted in FIG. 1. 
The goal of using the Velcro strap 58 is to prevent, or 40 
minimize, the hydrophone 54 from moving relative to the 
patient 13. As such, other common and well-understood 
devices and methods to attach the hydrophone 54 to the 
patient 13 may be used. For example, an adhesive such as 
tape, glue, or the like could secure the hydrophone 54 to the 45 
patient's chest 56. 
2 and other possible embodiments of a HAT apparatus. 
In the preferred method for HAT treatment, the HAT 
apparatus ensonifies a patient 13 with acoustic waves at 
specified frequencies. The patient's lungs are thereby caused 
to vibrate and respiratory secretions are mobilized in order 
to be removed from the lungs by the patient 13. 
The present invention is not limited to operation at a 
particular frequency, although low frequencies are generally 
desirable in HAT. For example, the frequencies used are 
generally below 120 Hertz. Although there is no required 
frequency of operation, operation at a fundamental resonant 
The hydrophone 54 monitors the level of acoustic exci-
tation imparted on the patient 13 during treatment, as 
described in detail below. This monitoring assists in main-
taining a safe and effective treatment environment. The 
hydrophone 54 relays to the computer 33 signals from which 
can be determined the frequency and amplitude at which a 
person's lungs are oscillated. 
The exemplary HAT apparatus 10 described above and 
pictured in FIG. 1 is only an example of a HAT apparatus. 
An alternative embodiment of a HAT apparatus would be a 
HAT apparatus more suited for home use. For example, the 
chamber could comprise a bath tub, jacuzzi, or whirlpool/ 
spa. A simple underwater speaker or transducer system 
could be used to deliver the acoustic waves into the water 
chamber. Such alternative apparatuses are intended to be 
encompassed within the scope of the present invention. 
FIG. 2 depicts an alternative embodiment of a HAT 
apparatus 60 particularly suited for home use. The alterna-
tive HAT apparatus 60 is very similar to the first exemplary 
HAT apparatus 10, however, the chamber 61 is preferably 
constructed of a plastic or fiberglass material. Additionally, 
50 frequency of a patient's lung is desired. Operation at the 
resonant frequency is desirable from an efficiency standpoint 
in that the patient's lungs would exhibit the maximum 
response for the least amount of energy input. Additionally, 
when the lung is excited at its resonant frequency, the result 
55 is that the lung responds in its fundamental oscillatory mode. 
That is, all the lung tissue moves uniformly, leading to more 
effective therapy. 
The amount of energy put into the acoustic waves (the 
amplitude of the waves) is of some importance in that the 
60 amplitude of the acoustic waves should preferably be kept 
below a level that might cause physical harm to a patient 13. 
While the actual amplitude limit depends on a variety of 
factors, it is preferred, and well-within safety limits, to keep 
the sound pressure level used in HAT to below 160 dB re 1 
65 µPa, as measured in the fluid 12 at the lungs. This level 
corresponds to safety levels established by the United States 
Navy. However, the safety limit of 160 dB re 1 µPa is based 
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in large part on the more restrictive sensitivity of a person's 
head to acoustic vibrations. Since the head 14 of the patient 
13 is above the fluid 12, the exemplary HAT apparatus 10 
and could very well operate safely at amplitudes above 160 
dB re 1 µPa. 
It is preferred that the pressure amplitude is high enough 
to be of therapeutic value. It has been determined in clinical 
tests that a level of at least 158 dB re 1 µPa is therapeutic. 
Of course, the present invention is expressly not limited to 
a specific pressure amplitude and may be operated at a lower 
(or higher) amplitude level. Indeed, lower pressure ampli-
tudes may be preferred if proven to be therapeutic. The 
computer 33 is programmed to maintain the pressure level at 
the lung (as measured by the hydrophone 54) at a therapeutic 
and safe level, 158 dB re 1 µPa in the preferred embodiment. 
Because the resonant frequency of each individual's lung 
is different, and the resonant frequency of a given individu-
al's lung may vary from day to day, the first step of the 
preferred treatment is to determine the resonant frequency of 
the patient's lungs. This step is not absolutely necessary, 
however, because as noted above, the particular frequency of 
operation is not critical to the present invention. 
A. Determination of the Resonant Frequency 
As depicted in FIG. 3, a first step in determining a 
resonant frequency of a patient's lungs is to begin with a 
chamber 11, as described above in reference to FIG. 1 
without a patient 13 in the chamber 11. FIG. 3 depicts such 
an "empty" chamber 11. Then the hydrophone 54 that will 
be used on the patient 13, as described above in reference to 
FIG. 1, is lowered into the fluid 12 in the chamber 11. The 
level of the fluid 12 is adjusted such that it is the same height 
on the side wall 19 of the chamber 11 as when the patient 13 
was seated in the chair 46. 
Once the hydrophone 54 is lowered into the fluid 12, the 
shaker 28 is activated, which drives the piston 24 resulting 
in the membrane 23 flexing into and out of the chamber 
interior. The activation of the shaker 28/piston 24/membrane 
23 creates acoustic waves in the fluid 12. The hydrophone 54 
is used to monitor the acoustic waves. 
The piston 24 begins moving at 24 Hertz and the fre-
quency of movement is increased at the rate of approxi-
mately 1 Hertz per second to a maximum of 120 Hertz. Of 
course, this is just one example of how the frequency may 
be varied with time. For example, the frequency could begin 
at 120 Hertz and move downward to 24 Hertz, or another 
value, at different steps. The driving voltage is preferably 
kept constant at a level that maintains the amplitude of the 
acoustic waves, as measured at the hydrophone 54, several 
dB below the preferred therapeutic value of about 158 dB re 
1 µPa. 
The hydrophone 54 measures the response in the fluid 12 
to the acoustic waves generated by the oscillation of the 
membrane 23. This is converted to electrical signals and 
relayed to the computer 33. This first set of hydrophone data 
is band pass filtered, amplified, and digitized to be recorded 
10 
Once the hydrophone 54 is affixed adjacent to the 
patient's chest 56, the shaker 28 is activated which drives the 
piston 24 resulting in the membrane 23 flexing into and out 
of the chamber interior, which creates acoustic waves in the 
5 fluid 12. The piston 24 begins moving at 24 Hertz and the 
frequency of movement is increased at the rate of approxi-
mately 1 Hertz per second to a maximum of 120 Hertz. 
During the determination of the resonance frequency, the 
driving voltage is kept constant at a level that maintains the 
10 amplitude of the acoustic waves as measured at the hydro-
phone 54 several dB below the therapeutic value. As noted 
above, the preferred therapeutic value is about 158 dB re 1 
µPa, as measured in the fluid 12 at the patient's lungs. 
During the time that the patient's body 13 is ensonified by 
15 the acoustic waves, the hydrophone 54 measures the 
response of the patent's lungs. This is converted to electrical 
signals and relayed to the computer 33. The hydrophone data 
is band pass filtered, amplified, and digitized to be recorded 
by the computer for analysis. This data forms a second set 
20 of hydrophone data, as the first set of hydrophone data was 
collected as described above in reference to FIG. 3, while no 
patient 13 was in the fluid 12. 
The acoustic waves are generated by the membrane 23 
and travel through the fluid 12, which is water in this 
25 embodiment, to the patient's body 13. At the patient's body 
13, the waves remain largely unchanged as the body 13 is 
mostly water. The waves then travel through the patient's 
body 13 until the waves reach the boundary of the lungs. 
Because the lungs are largely air, there is an impedance and 
30 compliance mismatch at the lung surface and the lungs are 
caused to vibrate at the frequency of the acoustic wave. As 
noted above, at resonance, the lungs respond in a funda-
mental oscillatory mode with a relatively large amplitude. 
This results in uniform movement of the lung tissue, and not 
35 just movement of the air in the lungs. 
The hydrophone 54 measures the vibration of the lungs by 
detecting and measuring the acoustic pressure within the 
lungs generated by the underwater sound waves. Once the 
digitized hydrophone data is collected by the computer 33, 
40 the piston 24 ceases operation. 
Alternatively, the resonant frequency of the lungs could 
be determined by affixing one or more accelerometers to the 
chest 56 of a patient 13 and then going through the same 
process of ensonifying the patient 13 with acoustic waves of 
45 varying frequency. The accelerometers would measure the 
response of the patient's lungs by showing the acceleration 
and hence the displacement of the patient's chest 56. The 
disadvantage to this second preferred method is that the 
accelerometers must be securely affixed to the chest of the 
50 patient. Using a hydrophone is less intrusive to the patient. 
Alternatively, an ultrasound vibrometer could be used to 
determine resonant frequency of a patient's lungs. However, 
this method generally involves more costly equipment that 
is not necessary in the present treatment process. 
by the computer for analysis. Once this first set of digitized 55 
hydrophone data is collected by the computer 33, the piston 
To summarize, the computer 33 gathers two sets of 
digitized hydrophone data: a first set without a patient 13 in 
the fluid 12 (see FIG. 3) and a second set of data with the 
patient 13 seated in the fluid 12 (see FIG. 1). Then, the 
computer 33 is caused to normalize the two sets of hydro-
24 ceases operation. Note that this measurement needs to be 
done only once since typically nothing changes with the 
device. This task comprises a calibration of the internal 
acoustic field. 
The next step in the preferred method for determining the 
resonant frequency of a patient's lungs is to remove the 
monitor hydrophone 54 and permit a patient 13 to enter the 
chamber 11 and be seated on the chair 46. Then, as described 
60 phone data (one set with patient 13 and one set without 
patient 13) and plot the collected data, such as with a 
computer program like LABVIEW, Matlab or other similar 
software. The resonant frequency of the patient's lungs can 
be determined from the plot. 
in reference to FIG. 1 above, the hydrophone 54 is affixed to 65 
the chest 56 of the patient 13. FIG. 1 depicts the appropriate 
configuration for this next step. 
To normalize and plot the data, the computer 33 first 
computes a transfer function for the first set of data (with the 
patient 13 in the chamber 11) as a function of the frequency 
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of the piston 24. The computer 33 also computes a transfer 
function for the second set of data (without the patient 13 in 
the chamber 11) as a function of the frequency of the piston 
24. This procedure is well understood by those having 
ordinary skill in the art. 
The computer 33 then takes the ratio of the two transfer 
functions to arrive at a new normalized amplitude transfer 
function that will be used for determining the resonant 
frequency of the patient's lungs. In other words the com-
puter 33 makes the following computation: 
Where: 
Y is a transfer function of the normalized amplitude as a 
function of frequency; 
amplzung is a transfer function of the amplitude of the 
lung's response with the patient 13 in the chamber 11 
(the second set of data); and 
amplinput is transfer function of the amplitude of the 
acoustic pressure in the chamber 11 in the absence of 
the patient 13 (the first set of data). 
In other words, the computer 33 arrives at a normalized 
amplitude by computing the ratio of the amplitude of the 
lungs' vibratory response to the acoustic waves to the input 
acoustic pressure. The input acoustic pressure is the ampli-
tude of the acoustic pressure in the chamber 11 under 
identical drive conditions, measured by the same hydro-
phone 54 in approximately the same location with the 
patient 13 not in the chamber 11. This latter measurement is 
made with the level of fluid 12 in the chamber 11 set to be 
the same as it is when the patient 13 is in the chamber 11. 
By using the driving the piston 24 as described above, one 
obtains the transfer function Y as a function of excitation 
frequency. This transfer function Y is then plotted by the 
computer 33 versus the frequency of excitation of the piston 
24. 
FIG. 4 is a plot 70 for three typical patient's lungs 
responding to the acoustic waves during the resonant fre-
quency test described above. FIG. 4 is a plot 70 of the 
normalized amplitude of the lung's vibratory response ver-
sus the frequency of the piston 24, in Hertz. The normalized 
amplitude is plotted along the y-axis and the frequency is 
plotted along the x-axis. Note that the oscillations in the 
curves are due to the breathing of the patient 13. 
The resonant frequency of the patient's lungs is identified 
in the plot by the frequency corresponding to the maximum 
normalized amplitude on the curve associated with the 
patient. The three curves in the example plot 70 have a 
maximum of approximately 31 Hertz for patient 1 (71), 49 
Hertz for patient 2 (72), and 60 Hertz for patient 3 (73). 
These are typical resonant frequencies for patients. 
It should be noted that the underwater resonance fre-
quency of the lungs is orders of magnitude lower than for 
any other organ of the body. Resonance of a patient's lungs 
is a "spring-mass" resonance, where the compliance of the 
air filled lungs is the spring and the radiation mass of the 
surrounding fluid is the mass. The frequency is low because 
the lungs comprise a very soft spring which resonates 
against the very large radiation mass of the fluid. This is not 
a half wave-length type resonance. This resonance of the 
lungs, as described above, does not exist in air. 
The maximum point 71, 72, 73 and the corresponding 
resonant frequency can be identified by the computer 33 
automatically, by an operating technician or by the patient 
him/herself. If the computer 33 identifies the resonant fre-
12 
quency automatically, it is not necessary for the computer to 
actually printout a plot 70 of the data. A computer 33 can be 
programmed so as to identify the maximum point in a series 
of data without having a need to physically plot the data. 
5 B. Treatment Procedure 
For the preferred HAT treatment method, the patient 13 is 
seated within the chamber 11, as depicted in FIG. 1. The 
patient 13 is seated such that the level of the fluid 12 is 
approximately at the base of the patient's neck 53. In this 
10 way, the entire surface of the patient's lungs is surrounded 
by the chamber fluid 12. Having the patient's lungs sur-
rounded by the chamber fluid 12, is preferable because the 
fully submerged lungs receive acoustic pressure stimulation 
throughout the whole mass. Indeed, a limitation of the 
15 previous VEST™ therapy is that the lungs are not uniformly 
stimulated. 
Once the patient 13 is comfortable in the chamber 11, the 
therapy begins. The therapy involves causing the piston 24 
to oscillate at a certain frequency or group of frequencies. 
20 The piston 24 causes the membrane 23 to oscillate a certain 
frequencies and amplitude, which, in turn, generates acous-
tic waves in the fluid 12. The acoustic waves transmit 
through the fluid 12 to the surface of the patient's body 13. 
The vast majority of the organs of the human body are 
25 primarily composed of water. Only the lungs and the bones 
of a patient 13 are not primarily composed of water. Since 
the fluid 12 in the chamber 11 is water, the human body, with 
the exception of the lungs and the bones, is acoustically 
transparent in the water 12. In other words, the water 12 in 
30 the chamber 11 and the body's organs are matched in 
impedance and compliance. Because of the match, most 
visceral organs do not exhibit significant responses to an 
applied underwater acoustic field. 
In contrast, the air-water interface at the lung pleural 
35 surface provides an acoustic impedance and compliance 
mismatch. Due to the mismatch at the lung pleural surface, 
when the lung is exposed to an acoustic field, the lung is 
excited and begins to vibrate. As depicted in FIG. 4, the 
amplitude at which the lung vibrates changes as the fre-
40 quency of the acoustic waves change. 
As noted above, it is desirable for the treatment to occur 
at the resonant frequency of the lung and at a pressure 
amplitude of approximately 158 dB re 1 µPa. This ensures 
the most efficient transmission of energy from the acoustic 
45 waves to the lung surface. Furthermore, when the lung is 
submersed in water, and is stimulated at its resonance 
frequency underwater (which is usually different than the 
resonant frequency of a lung when not submersed in water), 
the lung surface oscillates uniformly at a fundamental oscil-
50 latory mode. The lung itself actually moves in uniform 
motion. This response is in contrast to a response of a 
patient's lung excited at its resonant frequency when the 
patient is not submersed in water. A patient that is not 
submersed exhibits a resonant response that results primarily 
55 in the movement of the air within the lung (Helmholtz 
Resonance). 
In an exemplary procedure using the HAT apparatus 10 
the treatment will take only thirty minutes. For ten minutes, 
the HAT apparatus 10 will generate acoustic waves at a 
60 frequency below the resonant frequency of the lung. In the 
exemplary implementation, the first frequency will be 
approximately 10 Hertz below the resonant frequency of the 
patient's lungs. The amplitude of this excitation is preferably 
158 dB re 1 µPa as measured by the monitoring hydrophone. 
65 Then, for ten minutes the piston 24 will operate at the 
resonant frequency of the patient's lungs. Although not 
required, the driving voltage amplitude may be lowered 
US 6,974,425 B2 
13 
during this phase of the treatment to maintain the pressure 
amplitude at the lung at the same level 158 dB re 1 µPa. 
Finally, the piston 24 will operate at 10 Hertz greater than 
the resonant frequency of the person's lungs again at voltage 
level chosen to produce a pressure of 158 dB re 1 µPa at the 5 
lungs. 
For example, in a typical patient, the piston 24 would 
operate at 30 Hz so as to generate an applied pressure 
amplitude of 158 dB re 1 µPa for ten minutes, at 40 Hz so 
as to generate an applied pressure amplitude of 158 dB re 1 10 
µPa for ten minutes, and finally at 50 Hz so as to generate 
an applied pressure amplitude of 158 dB re 1 µPa for ten 
minutes. Of course, this is just an example of a somewhat 
typical treatment which has been found to be effective and 
safe. Treatment times and frequencies, waveforms and 15 
amplitudes may be varied, for example broadband or mul-
tiple frequency signals within the frequency range may be 
utilized. For example, the frequency and amplitude of the 
acoustic waves may be varied as a function of time. On the 
other hand, it may be desirable in certain HAT treatment 20 
scenarios to cause the acoustic waves to be pulsed through 
the liquid. 
After receiving the HAT treatment, the patient 13 is 
removed from the chamber 11. The patient 13 may then 
engage in a period of huffing and coughing to remove 25 
sputum from the patient's lungs. Hufffing and coughing to 
remove sputum from the patient's lungs may also be per-
formed while patient is still in the water undergoing HAT 
therapy. 
The HAT apparatus and treatment method described 30 
above will be beneficial for the treatment of patients having 
cystic fibrosis. Additionally, the HAT apparatus and treat-
ment method may be used with any condition that would 
benefit from a lung therapy that assists in the mobilization of 
respiratory secretions. For example, the HAT apparatus and 35 
treatment method may be useful in treatments of chronic 
obstructive lung disease, pneumonia, and lung cancer. 
It should be emphasized that the above-described embodi-
ments of the present invention, particularly, any "preferred" 
embodiments, are merely possible examples of 40 
implementations, merely set forth for a clear understanding 
of the principles of the invention. Many variations and 
modifications may be made to the above-described 
embodiment(s) of the invention without departing substan-
tially from the spirit and principles of the invention. All such 45 
modifications and variations are intended to be included 
herein within the scope of this disclosure and the present 
invention and protected by the following claims. 
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recording a second output of said hydrophone as said 
acoustic vibration frequency is increased; 
computing a second transfer function of said second 
output; 
plotting a ratio of said first transfer function to said second 
transfer function versus said frequency of said acoustic 
vibrations; and 
identifying a maximum of said plot as a resonant fre-
quency of said lung. 
2. An apparatus for administering hydro-acoustic therapy 
for a patient, said device comprising: 
a chamber having a volume of water, said chamber further 
comprising rigid walls defining a generally cylindrical 
chamber, wherein said chamber further comprises an 
orifice in a wall, said orifice covered by a flexible 
membrane; 
a supporting structure in said chamber for permitting a 
person to sit in said chamber, partially submersed in 
said water, during treatment; 
a hydrophone positioned near a chest of said person in 
said water, said hydrophone for monitoring a response 
of said person to said acoustic waves; and 
a piston outside of said chamber directed to press against 
said membrane in order to cause said membrane to 
oscillate in periodic motion, said piston thereby gen-
erating acoustic waves in said water of said chamber, 
wherein said acoustic waves are low frequency vibra-
tions. 
3. A method for determining a resonant frequency of lungs 
of a patient, comprising the steps of: 
providing a chamber containing a fluid; 
placing a hydrophone in said chamber; 
causing acoustic vibrations in said fluid at a first fre-
quency and changing a frequency of said acoustic 
vibrations to a second frequency; 
processing a first output of said hydrophone as said 
acoustic vibration frequency is changed; 
placing a person in said chamber; 
positioning said hydrophone near the person; 
causing acoustic vibrations in said fluid at a third fre-
quency and changing said frequency of said acoustic 
vibrations to a fourth frequency; 
processing a second output of said hydrophone as said 
acoustic vibration frequency is changed; and 
comparing said first processed output to said second 
processed output such as to identify a resonant fre-
quency of said lung. We claim: 
1. A method for determining a resonant frequency of lungs 
of a patient, comprising the steps of: 
50 
4. The method of claim 3, wherein said processing of said 
first and second output comprises normalizing said first and 
second outputs. 
providing a chamber containing a fluid; 
placing a hydrophone in said chamber; 
causing acoustic vibrations at a first frequency and chang-
ing a frequency of said acoustic vibrations to a second 55 
frequency; 
recording a first output of said hydrophone as said acous-
tic vibration frequency is increased; 
computing a first transfer function of said first output; 
placing a person in said chamber such that a body of the 
person is immersed in said fluid; 
positioning said hydrophone near a chest area of the 
person; 
60 
causing acoustic vibrations at said first frequency and 65 
changing said frequency of said acoustic vibrations to 
said second frequency; 
5. The method of claim 4, wherein said normalizing 
comprises: 
computing a first transfer function of said first output; and 
computing a second transfer function of said second 
output. 
6. The method of claim 5, wherein said comparing step 
comprises: 
plotting a ratio of said first transfer function to said second 
transfer function versus said frequency of said acoustic 
vibrations; and 
identifying a maximum of said plot as said resonant 
frequency of said lung. 
7. The method of claim 4, wherein said processing step 
further comprises filtering, amplifying, and digitizing said 
first and second outputs. 
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tic vibrations to a first frequency for about ten minutes and 
then setting the frequency of said acoustic vibrations to a 
second frequency for about 10 minutes. 
8. The method of claim 3, wherein said positioning step 
comprises placing said hydrophone in substantially the same 
position within said chamber as the hydrophone was placed 
when the person was not in the chamber. 
9. A method for the medical treatment of a person, said 
method comprising: 
providing a chamber containing a fluid; 
16. The method of claim 9, wherein said first frequency 
5 comprises said resonance frequency and said second fre-
quency comprises a frequency greater than said resonance 
frequency. 
placing a person in said chamber such that a body of the 
person is immersed in said fluid; 
10 
determining a resonance frequency of a lung of said 
person; 
introducing acoustic vibrations into said fluid, said acous-
tic vibrations having a frequency; and 
17. The method of claim 16, wherein said acoustic vibra-
tions comprise an amplitude of about 158 dB re 1 µPa. 
18. The method of claim 17, wherein said sequential 
adjusting step comprises setting the frequency of said acous-
tic vibrations to a first frequency for about ten minutes and 
then setting the frequency of said acoustic vibrations to a 
second frequency for about 10 minutes. 
19. The method of claim 9, wherein said first frequency 
comprises a frequency greater than said resonance frequency 
and said second frequency comprises said resonance fre-
quency. 
sequentially adjusting the frequency of said acoustic 15 
vibrations between a first frequency and a second 
frequency, wherein one of said frequencies comprises 
said resonance frequency and the other of said frequen-
cies comprises a frequency either greater than or less 
than said resonance frequency. 
20. The method of claim 19, wherein said acoustic vibra-
20 tions comprise an amplitude of about 158 dB re 1 µPa. 
10. The method of claim 9, wherein said first frequency 
comprises said resonance frequency and said second fre-
quency comprises a frequency less than said resonance 
frequency. 
11. The method of claim 10, wherein said acoustic vibra-
tions comprise an amplitude of about 158 dB re 1 µPa. 
12. The method of claim 11, wherein said sequential 
adjusting step comprises setting the frequency of said acous-
21. The method of claim 20, wherein said sequential 
adjusting step comprises setting the frequency of said acous-
tic vibrations to a first frequency for about ten minutes and 
then setting the frequency of said acoustic vibrations to a 
25 second frequency for about 10 minutes. 
tic vibrations to a first frequency for about ten minutes and 
then setting the frequency of said acoustic vibrations to a 30 
second frequency for about 10 minutes. 
22. The method of claim 21, wherein said placing step 
comprises immersing the person in said fluid such that a 
body of the person is fully immersed in said fluid below a 
neck area of the person. 
23. The method of claim 22, wherein said fluid comprises 
water. 
13. The method of claim 9, wherein said first frequency 
comprises a frequency less than said resonance frequency 
and said second frequency comprises said resonance fre-
quency. 
14. The method of claim 13, wherein said acoustic vibra-
tions comprise an amplitude of about 158 dB re 1 µPa. 
15. The method of claim 14, wherein said sequential 
adjusting step comprises setting the frequency of said aeons-
24. The method of claim 23, further comprising the step 
of positioning a monitoring device near a chest area of the 
person such that an effect of said acoustic vibrations on the 
35 person is monitored. 
25. The method of claim 24, wherein said monitoring 
device comprises a hydrophone. 
* * * * * 
